Zevaquenabant

N/A

Report date: 2024/11/07 17:27:41
NME

Base Information

Drug NameZevaquenabant
Drug Alias NameMRI-1867(S)-MRI-1867INV-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid CB1 receptor antagonistsNitric oxide synthase, inducible antagonists
TargetsCannabinoid CB1 receptorNitric oxide synthase, inducible
Therapy Area/IndicationsScleroderma, Systemic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNational Institutes Of Health
China Registration ClassN/A

Develop Information

Active CompaniesNational Institutes Of HealthInversago Pharma Inc
Inactive CompaniesN/A
Active IndicationsScleroderma, Systemic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A